Skinbiotherapeutics Plc Stock Annual Yield
| SBTX Stock | 16.00 0.12 0.76% |
SkinBioTherapeutics PLC fundamentals help investors to digest information that contributes to SkinBioTherapeutics' financial success or failures. It also enables traders to predict the movement of SkinBioTherapeutics Stock. The fundamental analysis module provides a way to measure SkinBioTherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SkinBioTherapeutics stock.
SkinBioTherapeutics |
SkinBioTherapeutics PLC Company Annual Yield Analysis
SkinBioTherapeutics' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, SkinBioTherapeutics PLC has an Annual Yield of 0.0%. This indicator is about the same for the Personal Care Products average (which is currently at 0.0) sector and about the same as Consumer Staples (which currently averages 0.0) industry. This indicator is about the same for all United Kingdom stocks average (which is currently at 0.0).
SkinBioTherapeutics Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SkinBioTherapeutics' direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SkinBioTherapeutics could also be used in its relative valuation, which is a method of valuing SkinBioTherapeutics by comparing valuation metrics of similar companies.SkinBioTherapeutics is currently under evaluation in annual yield category among its peers.
SkinBioTherapeutics Fundamentals
| Return On Equity | -1.19 | ||||
| Return On Asset | -0.61 | ||||
| Operating Margin | (13.01) % | ||||
| Current Valuation | 33.52 M | ||||
| Shares Outstanding | 228.44 M | ||||
| Shares Owned By Insiders | 19.32 % | ||||
| Shares Owned By Institutions | 16.45 % | ||||
| Price To Book | 9.93 X | ||||
| Price To Sales | 231.45 X | ||||
| Revenue | 132.06 K | ||||
| Gross Profit | 45.34 K | ||||
| EBITDA | (2.96 M) | ||||
| Net Income | (2.84 M) | ||||
| Total Debt | 100.65 K | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (2.65 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 56.0 | ||||
| Number Of Employees | 11 | ||||
| Beta | 1.75 | ||||
| Market Capitalization | 37.41 M | ||||
| Total Asset | 2.59 M | ||||
| Retained Earnings | (11.12 M) | ||||
| Working Capital | 1.19 M | ||||
| Net Asset | 2.59 M |
About SkinBioTherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SkinBioTherapeutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SkinBioTherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SkinBioTherapeutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SkinBioTherapeutics Stock Analysis
When running SkinBioTherapeutics' price analysis, check to measure SkinBioTherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SkinBioTherapeutics is operating at the current time. Most of SkinBioTherapeutics' value examination focuses on studying past and present price action to predict the probability of SkinBioTherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SkinBioTherapeutics' price. Additionally, you may evaluate how the addition of SkinBioTherapeutics to your portfolios can decrease your overall portfolio volatility.